These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 16101159

  • 1. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
    Gavrilov V, Steiner M, Shany S.
    Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
    [Abstract] [Full Text] [Related]

  • 2. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 3. Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
    Andrews J, Djakiew D, Krygier S, Andrews P.
    Cancer Chemother Pharmacol; 2002 Oct 01; 50(4):277-84. PubMed ID: 12357301
    [Abstract] [Full Text] [Related]

  • 4. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 01; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 5. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 6. Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analog.
    Berkovich L, Ben-Shabat S, Sintov AC.
    Anticancer Drugs; 2010 Jul 01; 21(6):609-18. PubMed ID: 20335794
    [Abstract] [Full Text] [Related]

  • 7. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
    Myrthue A, Rademacher BL, Pittsenbarger J, Kutyba-Brooks B, Gantner M, Qian DZ, Beer TM.
    Clin Cancer Res; 2008 Jun 01; 14(11):3562-70. PubMed ID: 18519790
    [Abstract] [Full Text] [Related]

  • 8. Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells.
    Andrews P, Krygier S, Djakiew D.
    Cancer Chemother Pharmacol; 2002 Mar 01; 49(3):179-86. PubMed ID: 11935209
    [Abstract] [Full Text] [Related]

  • 9. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY, Ly LH, Peehl DM, Feldman D.
    Endocrinology; 1997 Aug 01; 138(8):3290-8. PubMed ID: 9231780
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
    Andrews P, Zhao X, Allen J, Li F, Chang M.
    Cancer Chemother Pharmacol; 2008 Feb 01; 61(2):203-14. PubMed ID: 17447067
    [Abstract] [Full Text] [Related]

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 12. Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug.
    Wang YR, Wigington DP, Strugnell SA, Knutson JC.
    Anticancer Res; 2005 Nov 01; 25(6B):4333-9. PubMed ID: 16309237
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
    Angelucci C, Iacopino F, Lama G, Capucci S, Zelano G, Boca M, Pistilli A, Sica G.
    Anticancer Res; 2004 Nov 01; 24(5A):2729-38. PubMed ID: 15517879
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar 01; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 15. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
    Krishnan AV, Shinghal R, Raghavachari N, Brooks JD, Peehl DM, Feldman D.
    Prostate; 2004 May 15; 59(3):243-51. PubMed ID: 15042599
    [Abstract] [Full Text] [Related]

  • 16. 1,25(OH)2D3 and dihydrotestosterone interact to regulate proliferation and differentiation of epiphyseal chondrocytes.
    Krohn K, Haffner D, Hügel U, Himmele R, Klaus G, Mehls O, Schaefer F.
    Calcif Tissue Int; 2003 Oct 15; 73(4):400-10. PubMed ID: 12874696
    [Abstract] [Full Text] [Related]

  • 17. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
    Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF.
    Cancer Epidemiol Biomarkers Prev; 1998 May 15; 7(5):391-5. PubMed ID: 9610788
    [Abstract] [Full Text] [Related]

  • 18. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T, Gery S, Yin D, O'Kelly J, Binderup L, Lemp N, Taguchi H, Koeffler HP.
    Cancer Res; 2005 Jun 01; 65(11):4762-8. PubMed ID: 15930295
    [Abstract] [Full Text] [Related]

  • 19. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA, Thompson TA, Church DR, Ariazi EA, Wilding G.
    Prostate; 2003 May 15; 55(3):159-67. PubMed ID: 12692781
    [Abstract] [Full Text] [Related]

  • 20. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
    Zhao XY, Peehl DM, Navone NM, Feldman D.
    Endocrinology; 2000 Jul 15; 141(7):2548-56. PubMed ID: 10875257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.